Navigation Links
Banning the drug Valdecoxib In India

The National Pharmaco Vigilance Advisory Committee has prohibited the sale and manufacture of the drug// Valdecoxib, indicated for arthritis and acute pain in India under the Drugs and Cosmetics Act.

Studies done abroad have indicated that the drug Valdecoxib is found to double the risk of heart attacks and strokes and also result in severe skin reactions.

Although some of the leading pharmaceutical companies have stopped manufacturing it and have withdrawn the drug from the Indian market, a few leading companies differ in opinion and have adopted a “wait and watch” approach as a result of which they have still not withdrawn the drug from the market.

Some of the leading drugs manufacturing companies in India also have a major market-share in the product, with sales amounting to Rs.25 crore another reason for their reluctance to withdraw the drug from the market.

According to US officials, the request for withdrawal of the drug was made by the FDA after seeking approval from a committee they had constituted for advice on the issue. Higher authorities in the Indian Drug Manufacturers Association however feel that based on US models, the drug should not be banned in India as each countries requirement are different and withdrawal and approval of drugs should be made accordingly.

'"/>




Page: 1

Related medicine news :

1. Banning Smoking in the Home Helps Infants
2. Doctors Ask MPs To Protect Human Rights By Banning Smoking In Enclosed Public Spaces
3. Punjab Plans of Banning Sex Determination Kit from US
4. Indian Pharmaceutical Industries Stops Manufacturing And Sale Of Valdecoxib
5. Is Diabetes the Leading Cause of Kidney Failure in India
6. AIDS Disaster in India is Imminent
7. Indian Prime Minister has successful Knee Replacement Surgery
8. International community warns India on HIV situation
9. India takes on foot-and-mouth disease by vaccinating animals
10. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
11. India to benefit from pharma companies move
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Banning the drug Valdecoxib India

(Date:7/29/2015)... ... July 30, 2015 , ... ... their clients, BOC approved provider of online continuing education courses for Athletic ... to their exclusive Andrews Research and Education Sports Medicine Series. , The new ...
(Date:7/29/2015)... ... ... According to data released today by the Centers for Medicare & Medicaid Services, ... $32.50, a figure far lower than was originally projected, the Pharmaceutical Care Management Association ... in American health care. By offering an abundance of competing choices in each region ...
(Date:7/29/2015)... ... ... article published July 23 by the Daily Mail, a new online tool developed ... do in terms of physical activity and caloric intake to lose weight. Based on a ... of calories a person needs to consume to maintain or lose weight at a rate ...
(Date:7/29/2015)... ... ... Sports fans young and old at the National Cherry Festival in Traverse ... joined by A Forever Recovery, a holistic treatment center for substance abuse located in ... Offensive Lineman Lomas Brown, and Tight End Rob Rubick signed foam footballs, provided by ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Pharmacy Collaborative for retail healthcare providers begins in Kissimmee, Fla. The two-day ... and physician assistants can work together to expand access to affordable, high quality ...
Breaking Medicine News(10 mins):Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:New NIH Body Weight Planner Illustrates the Need for Reduced Caloric Intake When Trying to Lose Weight, Says Beverly Hills Physicians 2Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 2Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 3Health News:Last Chance for Pharmacists, Nurse Practitioners, Physician Assistants in Retail Clinics to Register for Collaborative Learning Program 4
... returned to Iraq's holy city of Najaf on Friday after ... head of one of the most powerful parties in the ... included medical tests in the United States and treatment in ... and will be there for a long time, after he ...
... now breathe a sigh of relief for researchers at ... developed two robotic devices that mimic the human ankle, ... ,Dr. Hugh Herr, Assistant Professor and Director of the ... Discovery News as saying that these spring-enabled, motor-driven devices ...
... identified a tiny bit of genetic code, which helps the ... ,The genetic code is called miR-34a, a microRNA ... are likely to become malignant because of damaged genes in ... acid (RNA), which stick to messenger RNAs, and prevent proteins ...
... death campaigners on Friday expressed concerns that the number of ... in Australia. ,The number of children dying from ... to 87 in 2005, SIDS and Kids Western Australia spokeswoman ... safe sleeping practices for babies had reduced cot deaths from ...
... has issued a warning in all districts after reports from ... eradicated from the world 30 years ago, along the Bangladesh-Myanmar ... Sanchita Bakshi said border security agencies have been asked to ... the symptoms of the disease. ,Local reports said ...
... TV reality show highlighting the need for more organ donors, ... a swirl of controversy, a Dutch channel Friday was to ... her kidney. ,The controversy stirred by "The Big ... but public broadcaster BNN is determined to go ahead. ...
Cached Medicine News:Health News:Top Iraqi Shiite Leader Returns Home 2Health News:Now, Natural Looking, Energy Efficient Robotic Ankles for Amputees 2Health News:Genetic Code That Helps Kill Colon Cancer Cells Identified 2Health News:Small Pox Scare Put West Bengal on High Alert 2Health News:Shock TV Reality Organ Donor Show Goes on Air 2Health News:Shock TV Reality Organ Donor Show Goes on Air 3
(Date:7/29/2015)... , July 29, 2015 WuXi PharmaTech ... R&D capability and technology platform company serving the pharmaceutical, ... China and the United ... financial results for the second-quarter of 2015 after the ... 2015 (which will be Friday morning, August 14, 2015 ...
(Date:7/29/2015)... 2015  Depomed, Inc. (NASDAQ: DEPO ) ("Depomed" ... of Directors, after careful consideration and with the ... has unanimously rejected the purported revised, highly conditional, ... (NASDAQ: HZNP ) ("Horizon") to acquire all ... all-stock transaction (the "July 21 Proposal"). ...
(Date:7/29/2015)... REDMOND, Washington , 29 luglio 2015 /PRNewswire/ ... tedesco ha scoperto che l,ingestione quotidiana del probiotico ... microbiota intestinale umano e modifica la produzione intestinale ... insulina. Lo studio riguardava la somministrazione quotidiana di ceppo ... ATCC SD-5865) in compresse utilizzando il sistema di ...
Breaking Medicine Technology:WuXi PharmaTech Schedules Second-Quarter 2015 Earnings Release 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2
... As part of its ongoing work in the prevention ... Diagnostics is pleased to announce its sponsorship of the ... a kick-off event at Loyola University in Chicago on ... the goal of World MRSA Day is to highlight ...
... 28 Chimerix, Inc., a pharmaceutical company developing orally-available ... and Chief Executive Officer, will present a corporate overview ... 5th, 2010 at 2:00pm PT.  The conference is being ... Mr. Moch will discuss the company,s antiviral ...
Cached Medicine Technology:Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day 2Roche Diagnostics Supports Fight Against MRSA as a Sponsor of Annual World MRSA Day 3Chimerix to Present at 9th Annual BIO Investor Forum 2
Cleveland Bone Cutter #5, 17cm, 6-3/4"...
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Diamond Point Bone Probe with Ortho-Grip® silicone rubber palm style handles and,stainless steel impactor caps....
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
Medicine Products: